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Kurzreferat: 
Aktuelle Studien lassen darauf schließen, dass Stammzellen, isoliert aus dem 
Fettgewebe (adipose tissue-derived stem cells – ASCs), zur Behandlung von 
Sehnenrupturen verwendet werden können. Bisherige Ergebnisse belegen dies 
aufgrund von histologischen, immunhistologischen und verschiedensten 
biomechanischen Untersuchungen. Das Ziel dieser Arbeit war es zu 
untersuchen, ob die Behandlung von Achillessehnen mit ASCs zu einer 
Verbesserung der Elastizität führt und ob man diesen Effekt objektiv mit Hilfe 
der Sonoelastographie demonstrieren kann. 
Es konnte gezeigt werden, dass Achillessehnen bei Behandlung mit ASCs auf 
einer Kollagenmatrix im Vergleich zu der Gruppe, behandelt nur mit 
Kollagenmatrix, einen signifikant niedrigeren Elastizitätsindex aufweisen 
konnten. Der Index-Wert entsprach dabei dem Niveau einer unverletzten 
Sehne. Weiterhin konnte dargestellt werden, dass die Sonoelastographie den 
Elastizitätsindex objektiv und valide abbilden kann. 
 
Schlüsselwörter: [Achillessehne], [adipose tissue-derived stem cells], 
[Elastizitaetsindex], [Sonoelastographie] 
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1. Zusammenfassung 
 
Ziel: Die Sonoelastographie kann mechanische Eigenschaften von Gewebe 
darstellen und ist daher geeignet Defekt- und Narbenbildung von 
Sehnengewebe darzustellen. Ziel der Studie war es, die Elastizität von 
Achillessehnengewebe nach autologer mesenchymaler Stammzellapplikation 
unter Verwendung der Sonoelastographie zu untersuchen. 
Material und Methodik: Die Achillessehne beider Hinterläufe wurde in neun 
Neuseeland Kaninchen vollständig durchtrennt. Anschließend wurden die 
Hinterläufe randomisiert drei Gruppen zugeteilt, wobei eine extrazelluläre Matrix 
mit Stammzellen (Gruppe 2, n=6)  und ohne Stammzellen (Gruppe 3, n=6) 
verwendet wurde. In der Kontrollgruppe wurde eine Sham-Operation 
durchgeführt (Gruppe 1, n=6). Die Extraktion und Applikation der 
mesenchymalen Stammzellen erfolgte aus dem nuchalen Fettkörper zum 
gleichen Zeitpunkt wie die Achillessehnendurchtrennung, um die Untersuchung 
an einem autologen Sehnenregenerationsmodell zu untersuchen. Nach 8 
Wochen wurden die Achillessehnen entnommen und die Elastizität mit einer 
hochauflösenden 6-15 MHz  Matrix–Linear-Sonde untersucht. Für jede Sehne 
wurde eine 20 Sekunden farbkodierte Sonoelastographie-Sequenz 
aufgezeichnet und 10 Farbhistogramme untersucht. Definierte Regions of 
Interests (ROIs) wurden über den Sehnendefekt (n=3) und über angrenzendes 
vitales Sehnengewebe (n=3) gelegt. Für die semiquantitativen Auswertungen 
wurden 180 Einzelmessungen aufgezeichnet und ausgewertet. 
Ergebnisse: In Gruppe 2 konnte für Achillessehnen mit beladener Matrix eine 
höhere Elastizität im Vergleich zu Achillessehnen mit unbeladener Matrix in 
Gruppe 3 gemessen werden (p<0.001; ANOVA). Hinsichtlich des Elastizitäts-
Index (EI) von unbehandeltem Sehnengewebe (Gruppe 1) und Sehnengewebe 
mit beladener Matrix (Gruppe 2) konnte kein Unterschied gefunden werden 
(p>0.05). Für alle Einzelmessungen der verschiedenen Messzeitpunkte konnte 
kein signifikanter Unterschied festgestellt werden (p>0.05). 
Schlussfolgerung: Unsere Ergebnisse zeigen, dass die Applikation von 
autologen mesenchymalen Stammzellen des Fettgewebes zu einer 
vollständigen Wiederherstellung der Elastizität des Sehnengewebes nach 
Achillessehnenverletzung führt. Außerdem konnte gezeigt werden, dass die 
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Sonoelastographie eine geeignete Methode ist, um die Regeneration der 
Elastizität nach Achillessehnenverletzung darzustellen und zu beurteilen. 
 
Schlüsselwörter:  
[Achillessehne], [adipose tissue-derived stem cells], [ Elastizitaetsindex], 
[Sonoelastographie] 
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2. Summary 
 
Purpose: Sonoelastography allows assessment of tissues’ mechanical 
properties and has recently been used to demonstrate the effects of Achilles 
tendon injury. The aim of the current study was to evaluate an ultrasound 
approach to depict elastic recovery after stem cell application on injured Achilles 
tendon. 
Materials and Methods: A rabbit achilles tendon injury model was used and 
randomized hindlimbs received either extracellular matrix with autologous 
adipose tissue-derived stem cells (group 2, n=6) or without (group 3, n=6). 
ASCs were harvested from the rabbits’ nuchal fat body at the same time as the 
tendon injury operation. Untreated Achilles tendon (group 1, n=6) served as 
controls but underwent sham-operation. Specimens were harvested after 8 
weeks and were longitudinal analyzed for elasticity using a high resolution 6-15 
MHz matrix linear probe. For each tendon, real-time color-coded 
sonoelastography sequences of 20 seconds were recorded and ten color 
histogram frames were obtained. Defined regions of interest (ROIs) were placed 
on the defect (n=3) and on adjacent uninjured tendon tissue (n=3). In total, 180 
measurements were obtained for semiquantitative analysis. 
Results: Repeated measures ANOVA demonstrated a higher elasticity for stem 
cell seeded matrix (group 2) in comparison to the unseeded matrix (group 3) 
(p<0.001; ANOVA).  No significant difference was found between the injured 
tendon tissue treated with stem cell seeded matrix (group 2) and uninjured 
Achilles tendons (group 1) (p>0.05). Moreover, no differences were found 
between the measurements at different time-points (p>0.05). 
Conclusion: The current study indicates that autologous mesenchymal stem cell 
application successfully restores mechanical properties of injured tendon tissue. 
Furthermore, sonoelastography enables to monitor elasticity of injured Achilles 
tendon after stem cell application. 
 
Keywords: [Sonoelastography], [Achilles tendon], [Elasticity Index], 
[Adipose tissue-derived stem cells] 
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3. Abbreviations 
 
ASCs     Adipose tissue-derived stem cells 
ANOVA    Analysis of variance 
MHz     Mega Hertz 
n     Number 
ROI     Regions of interest 
EI     Elasticity index 
i.e.     Id est 
ECM     Extracellular matrix 
TSPC     Tendon stem/progenitor cell 
Bgn     Biglycan 
Fmod     Fibromodulin 
VEGF     Vascular endothelial growth factor 
IGF-1     Insulin-like-growth-factor 1 
PDGF     Platelet derived growth factor 
TGF-β     Transforming growth factor β 
bFGF     Basic fibroblast growth factor 
MSC     Mesenchymal stem cell 
BMSC     Bone marrow-derived mesenchymal stem 
cell 
ACL     Anterior crucial ligament 
AT     Achilles tendon 
BMMC     Bone marrow mononuclear cells 
BMC     Whole bone marrow cells 
PT     Patellar tendon 
RC     Rotator cuff 
SMSC     Synovial mesenchymal stem cells 
SE     Sonoelastography 
MRI     Magnetic resonance imaging 
PBS     Phosphate bufferd saline 
α-MEM     α-modification of Eagle’s medium 
FBS     Fetal bovine serum 
DAPI     4',6-diamidino-2-phenylindole 
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DMEM     Dulbecco's Modified Eagle's medium 
DAB     3,3′-Diaminobenzidine 
HRP     Horseradish peroxidase 
BSA     Bovine serum albumin 
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4. Introduction 
 
4.1 Achilles tendon 
 
4.1.1 Extracellular matrix and stem cells in tendon tissue 
 
The Achilles tendon is the strongest and sturdiest tendon in the human body1 
and serves as connective tissue which physically binds muscles (i.e. Musculus 
gastrocnemius) to skeletal structures2 (i.e. Calcaneus). This facilitates 
enhancing joint stability and locomotion3. Tendon tissue has a multi-unit 
hierarchical organization of collagen molecules, fibrils, fibers, bundles, fascicles 
and tendon units, all running parallel to the tendon’s longitudinal axis3 designed 
to resist tensile load4. 
 
 
Figure 1: A drawing scheme of the multi-hierarchical structures of the tendon
3. 
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The structure of the extracellular matrix (ECM) molecules determines the 
physiological function and the mechanical strength of tendons3. The 
predominant molecule of tendon tissue is collagen I, which constitutes about 
95% of the total collagen5. The overall content of cells is low6 and primarily 
comprises of tenocytes and fibroblasts also referred to as tenoblasts. Both cell 
types are of mesenchymal origin and represent 90-95% of the cellular 
elements4, in tendon tissue. The premature fibroblast differentiates into a 
tenocyte7, featured with a very limited proliferation capacity8. Fibroblasts are 
responsible for synthesizing extracellular matrix proteins (e.g. collagen, 
fibronectin, proteoglycan), which aggregate to a collagen matrix. In addition, 
fibroblasts are responsible for remodeling the collagen matrix during tendon 
healing3,8. This comprises localized matrix formation and degradation which is 
crucial for tendon healing, adaptation to exercise, and tendon growth8. 
Recently, it has been shown, that tendon stem/progenitor cells (TSPCs) reside 
in ECM composed niche in tendon tissue and are controlled by biglycan (Bgn) 
and fibromodulin (Fmod). Moreover, isolated TSPCs could regenerate tendon-
like tissues after extended expansion in vitro and transplantation in vivo9. 
However, repair mechanism of these stem cells is limited due to low cell 
number in tendon tissue. 
Thus, limited healing of tendon tissue is emphasized by poor vascularization 
and nerve supply10 as well as its low metabolic rate11. Additionally, Åström12 et 
al. could demonstrate that mechanical loading but most important aging 
diminish the blood flow supplying the Achilles tendon. 
 
4.1.2 Tendon regeneration and repair 
 
A cascade of cellular and biochemical processes is initiated in order to restore 
tendons elasticity after injury. The initial stage involves tissue inflammation 
which attracts cells (e.g. inflammatory cells especially neutrophils, erythrocytes) 
from tissue adjacent to the side of injury13. Recruited fibroblasts maintain 
production of extracellular matrix during the proliferative phase. But new 
synthesized extracellular matrix is assembled in a random manner containing 
large number of cells and high amount of type III collagen14,15. Moreover, 
angiogenesis occurs during this stage13. Decrease of cellularity and type III 
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collagen starts 6 – 8 weeks after injury which is a characteristic feature of the 
remodeling stage. At the same time collagen I synthesis, as a crucial step for 
tensile strength16, increases and provides longitudinal organized fibers along 
the lines of stress and a high rate of crosslinks which are responsible for tendon 
elasticity15,17. Additionally, elastic fibers with increased elastin deposition are 
observed13. 
During the different stages of tendon repair various growth factors activate and 
regulate the cellular response in a temporal and spatial manner. Vascular 
endothelial growth factor (VEGF) stimulates angiogenesis15 and is produced at 
a maximum level after the inflammatory phase. In contrast, Insulin-like-growth- 
factor-1 (IGF-1) has been reported to be up-regulated highest at the 
inflammatory phase stimulating migration and proliferation of fibroblast and 
inflammatory cells15,18. Moreover, IGF-1 enhances collagen synthesis during the 
stage of remodeling accompanied by improved tendon stiffness18. In addition, 
platelet derived growth factor (PDGF) can facilitate IGF-1 expression during the 
inflammatory phase of tendon healing and is also involved in the remodeling 
process18. Thus, a lack of IGF-1 has been shown to be associated with an 
insufficient repair response15. Noteworthy, increased cell proliferation and 
synthesis of various ECM components especially collagen I during the 
remodeling phase has been reported for application of PDGF in a dose 
dependent manner18. In addition, TGF-β initiates cell migration and collagen 
production19 and also effects the regulation of proteinases and fibronectin 
bindings20. But restored tendon tissue has thinner collagen fibrils which 
remain21 and provides less mechanical properties than native tissue causing 
failure of tendons strength and eventual might lead to re-rupture17.  
 
4.1.3 Application of growth factors for Achilles tendon injury 
 
Treatment options of Achilles tendon injury include nonsurgical treatment as 
immobilization in a cast or a functional brace22. Furthermore, surgical treatment 
exists and can decrease re-rupture rate23 compared to conservative treatment 
protocol with immobilization. Recent studies suggest that growth factor 
application during tendon healing can enhance functional repair and might 
reduce time of regeneration. To date various growth factors are investigated for 
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possible application to improve tendon healing whereas VEGF, IGF-1, TGF-β, 
PDGF and bFGF are best characterized and known for their role in tendon 
tissue regeneration18. 
The delivery of one growth factor or even a mixture is challenging since the 
dosage of these factors is critical during each stage of the regeneration 
process. Furthermore, the limited half-life of growth factors and their small size 
restrict their retention for a prolonged time at applied site of tissue. These 
claims are supported by Zhang et al.24 who showed that VEGF introduced 
exogenous to an injured tendon site can accelerate tensile strength just within 
the first 2 weeks postoperatively but no significant difference was seen after 4 
weeks compared to the control group. Similar results were reported by treating 
patellar tendon defects in rabbits with IGF-1 and TGF-β125. 2 weeks after 
administration a significant increase in ultimate stress, energy uptake, stiffness 
and force at failure were documented compared to the control group. 
Interestingly, 6 weeks after administration no significant difference was detected 
for all investigated parameters25. Thus, mesenchymal stem cells (MSCs) were 
suggested as an appropriate delivery method due to their engraftment at 
applied site and constant secretion of cytokines.  
 
4.1.4 Stem cells for tendon tissue regeneration 
 
Injury or degeneration of tissue of multicellular organisms can be restored by 
either scar formation or tissue regeneration. The capacity of regeneration is 
very limited to specific tissue ( e.g. epidermis, intestinal mucosa26). In contrast, 
tendon as a self-contained tissue lacks the property of adequate regeneration 
due to low cell numbers. 
Regenerative medicine is utilizing MSCs as a cell based tool since they show 
self-renewal and multi-lineage differentiation27. Furthermore, these cells have 
been shown to be hypo-immunogen due to the lack of the major 
histocompatibility complex-II molecular expression28. During the last decade 
different types of stem cells have been applied to tendon defects to investigate 
the potential for medical purposes in order to establish new experimental and 
clinical opportunities as seen in the Table 1. Regenerative medicine depends on 
stem cells that meet a number of qualities as 1. abundant appearance 2. 
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minimal invasive harvest 3. multi-linage differentiation and 4. safety and 
suitability for transplantation29.  
MSCs, as non-hematopoietic stem cells, have been primarily identified within 
the bone marrow stroma30 and were considered the most promising source for 
medical tissue engineering application for a long time31. However, current 
studies showed that MSCs resides in almost all post-natal organs and tissues32, 
including adipose tissue33 as well as tendon34.  In addition, Zuk et al.33 
demonstrated that the differentiation potential of ASCs is as effective as of other 
MSCs. 
 
Table 1. Compilation of cell therapies for tendon healing 
 
Cell type 
(Insertion) 
Animal, 
Tendon 
Major results Author 
(Year) 
BMSC (knitted scaffold) Rabbit, AT Improved biomechanics, histology (up to 4
th
 week) Ouyang
35
, (2003) 
BMSC (collagen gel) Rabbit, PT Improved biomechanics, histology 
No change in microstructure 
Awad
36
, (1999) 
BMSC (fibrin) Rabbit, AT Improved biomechanics, histology (at 3 weeks 
only) 
Chong
37
, (2007) 
BMMC (injected) Human RC All cases showed positive tendon integrity  
after 12 month, appears to be safe 
Ellera Gomes
38
, 
(2011) 
BMSC (collagen sponge) Rabbit PT Improved biomechanics , histology Juncosa-Melvin
39
, 
(2006) 
BMSC (collagen gel) Rabbit AT Improved biomechanics, histology Young
40
, (1998) 
MSC (injection) Rat, AT Improved biomechanics, healing, enthesis Nourissat
41
, (2010) 
BMC>MSC (injection) Rat, AT Improved biomechanics, increased Col I/III, VEGF 
and TGFbeta expression 
Okamoto
42
, (2010) 
TDSC (fibrin glue) Rat, PT Improved biomechanics, histology Ni
43
, (2012) 
SMSC (injection in bone 
tunnel) 
Rat ACL Accelerated tendon-bone healing, histology Ju
44
, (2008) 
ACL, anterior crucial ligament; AT, Achilles tendon; BMMC, bone marrow mononuclear 
cells; BMC, whole bone marrow cells; BMSC, bone marrow-derived mesenchymal 
stem cells; MSC, mesenchymal stem cells; PT, patellar tendon; RC, rotator cuff; 
SMSC, synovial mesenchymal stem cells; TDSC, tendon-derived stem cells; TGF, 
transforming growth factor; VEGF, vascular endothelial growth factor; >, greater than; 
 
 
4.1.5 ASCs for tendon tissue regeneration 
 
The use of adipose tissue-derived stem cells, in particular, for tissue 
engineering has obvious advantage compared to other stem cells. The 
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application of embryonic stem cells is very restricted due to potential problems 
of cell regulation, ethical problems and different national laws whereas 
autologous mesenchymal stem cells can be used without hesitation as there are 
no ethical or immunological matters33. 
On proliferation rate ASCs’ doubling time was 28 hours compared to BMSCs’ 
39 hours45. ASCs became popular for research and clinical application in first 
line because of equal efficiency regarding multi-lineage differentiation capacity 
and minimal invasive method of harvesting (local excision or suction-assisted 
liposuction46), low donor site morbidity47 and the abundance of adipose tissue in 
adult humans. Thus, a high number of stem cells can be obtained.  
Furthermore, general or spinal anesthesia is often required33 for bone marrow 
aspiration due to painful procedure. In addition, bone marrow aspiration is also 
known for yielding low numbers of MSCs (approximately 1 out of 105 adherent 
stromal cells)30. From this practical point of view an insufficient number of cells 
may necessitate an additional step of in vitro proliferation to generate a 
sufficient amount of cells for adequate clinical use. Additionally, liposuction 
might be more tolerated by patients than bone marrow aspiration due to its 
aesthetic effects. 
Based on these properties ASCs became a valuable tool for tissue engineering 
and regenerative medicine. Several studies have been carried out to investigate 
effect of ASCs on tendon healing. As one promising step Uysal et al.47 have 
enabled the differentiation of ASCs to tenocytes in vivo and furthermore 
demonstrated an improvement of tendons tensile strength after application of 
ASCs. In addition, tendons biomechanical properties enhance when combining 
MSCs with composite biomaterial scaffold48. Taken together, many studies 
concern themselves with the topic how new approaches using MSCs influence 
tendon healing and repair. These studies were mainly focused on established 
methods for assessing the grade of tendon healing like histology35,40,49, 
immunhistochemistry16,40,50 or biomechanical properties like tensile strength47 or 
maximum stress49.  
 
The current study did not investigated biomechanical surrogate endpoints (e.g. 
tensile strength, maximum load or load to failure) since it has been extensively 
applied by various studies in the recent past16,51. This study centered on how 
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elasticity might serve as a surrogate marker for tendon healing linked to 
superior outcome since the elasticity of uninjured tendon tissue is accompanied 
by high energy uptake and the ability to deform. 
 
4.2 Sonoelastography 
 
Various animal models have been applied to investigate the role of MSCs on 
tendon regeneration. Interestingly, studies revealed that stem cell application 
can improve histological and biomechanical parameters but only in the first 6 
weeks after tendon injury37. Moreover, at 12 weeks post-surgery, maximum 
strength is almost comparable to vital uninjured tendon tissue40. Macroscopical 
and histological scoring systems are already used to evaluate the quality of 
repaired tissue in tendon defect models10. However, a high number of animals 
have to be included in a study to investigate maximum force load and histology 
at various time points in a tendon injury model in order to ensure sufficient 
power for statistical analysis. 
Moreover, histological and immunohistological examinations as well as 
biomechanical tests for evaluation of different parameters are either not feasible 
or not established for in vivo use during the healing process. Therefore, these 
diagnostic tools are inadequate for clinical use in daily routine to monitor the 
healing process of tendons after stem cell application. 
Nevertheless, several techniques for in vivo evaluation of soft tissue, including 
tendon, are in clinical use. Magnetic resonance tomography, computer 
tomography and as the most widely-used ultrasound examination are tools for 
examination. However, the above mentioned diagnostic methods can only 
provide detailed information of tissue’s morphology but not of biomechanical 
properties. However, biomechanical testing seems to be the gold standard for 
evaluating the efficiency of suture techniques or tendon strength, 
respectively52,53. Among tensile strength, maximum load or load to failure16 
elasticity, respectively stiffness54, are biomechanical parameters of tendons. 
Thus, evaluation of tendon’s elasticity might be a suitable marker to depict the 
healing process of a tendon regardless whether tendon tissue was treated 
conservatively, with suture or by regenerative methods like stem cell 
application. 
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Sonoelastography (SE), as a new and appropriate diagnostic tool for soft tissue, 
was first introduced in the early 1990s for in vitro use and subsequently evolved 
into in vivo use for imaging55,56 to enable in vivo real-time measurement of 
tissue elasticity57. 
Sonoelastography is based on some basic principles allowing a qualitative 
determination of tissue elasticity. Manual palpation is one of the oldest medical 
examination methods58. Even nowadays it continues to be of great value in 
medicine, both practiced by professionals and as a technique for self-
examination for lymph nodes, breasts, thyroid or Achilles tendon rupture. 
However, palpation is limited to superficial accessible structures and the 
interpretation is very limited due to a high subjectivity for information sensed by 
the fingers59. Like manual palpation sonoelastography detects elastic properties 
of tissue by comparing the grade of deformation between different types of 
tissue or between different regions of interest. Therefore the examiner performs 
strain with the ultrasound probe on structures amenable to compression. The 
maximum of displacement between two image points of the ultrasound B-mode 
in a determined time interval is computed by the instrument’s software. The 
software generates a color-coded image, which displays certain displacements 
in a correspondent color which is superimposed on the B-mode image. The 
most common color definition depicts hard tissue as blue, intermediate as green 
and soft as red. The newest generation of sonoelastography device assigns a 
numerical value, known as elasticity index (EI) to each grade of color. This tool 
gives the examiner an opportunity to objectify elasticity in a more precise way. 
Constant and uniform compression and decompression must be applied to the 
tendon during sonoelastography in order to avoid misinterpretation and artifacts 
as well as to assure most exact values. Therefore modern software provides a 
visual indicator displayed on the monitor. 
Recent studies using SE showed that elastic measurements of different types of 
tissue provide promising and useful result for diagnosis59–62. 
For tendon, in particular, Pedersen et al.63 demonstrated that sonoelastography 
seemed to be as feasible as ultrasound and MRI assessing tendon alteration 
and furthermore was superior depicting subclinical alteration not detectable with 
conventional ultra sound. In addition, in a different study sonoelastography was 
able to distinguish between ruptured and healthy tendon by measuring 
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elasticity64. However, this study only used a grading of tendon elasticity (i.e. 
intermediate, hard, hardest) instead of EI. Moreover, every single tendon 
suffering a rupture exhibited heterogeneous structure during SE, whereas all 
healthy Achilles tendons had a homogeneous or relatively homogeneous 
structure. However, this study admits limitations due to high influence of the 
pressure of the probe on the tissue performed by the examiner. Taken together, 
the above mentioned findings support various studies which describe 
sonoelastography as a promising quantitative tool to characterize alteration in 
morphology or biomechanics induced by previous injury65. 
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5. Aim of the study 
 
The current study aimed to investigate whether: 
 
i) ASCs are suitable to improve Achilles tendon elasticity when placed at 
the site of injury  
ii) Sonoelastography is an appropriate and examiner independent tool to 
investigate elasticity of tendon tissue 
iii) The content of Collagen I is changed by ASCs application  
iv) ASCs are able to engraft at the side of application and survive at least 8 
weeks 
v) ASCs harvested from rabbit’s nuchal fat body have multilineage 
pontential 
vi) ASCs are able to change cell morphology and cell organization 
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6. Materials and methods 
 
6.1 Materials 
 
6.1.1 Substances 
 
Povidone iodine    Sigma-Aldrich, St.Loise, MO, USA 
Cefazolin     Pfizer, NYC, NY, USA 
Blendzyme III     Roche Diagnostics, Basel, CH 
PBS      Sigma-Aldrich, St.Loise, MO, USA 
Hanks Balanced Salt Solution  Cellgro, Corning, NY, USA 
α-modification of Eagle’s medium  Cellgro, Corning, NY, USA 20% 
FBS      PAN Biotech, Aidenbach, Germany 
Penicillin- Streptomycin   Sigma-Aldrich, St.Louise, MO, USA 
DAPI stock solution    Sigma-Aldrich, St.Louise, MO, USA 
Buprenex     Reckitt Benckiser, Slough, UK 
Meloxicam     Norbrook, Newry, North Ireland 
Fentanyl citrate    Sandoz, Holzkirchen, Germany 
Buthanasia solution    Virbac, Carros, France 
Moist saline dressing    Sigma-Aldrich, St.Louise, MO, USA 
Trypsin      PAN Biotech, Aidenbach, Germany 
DMEM, low glucose with L-glutamine Life Technologies, Carlsbad, CA, USA 
Isobutyl-methylxanthine   Sigma-Aldrich, St.Louise, MO, USA 
Dexamathasone    Sigma-Aldrich, St.Louise, MO, USA 
Indomethacin     Sigma-Aldrich, St.Louise, MO, USA 
Bovine panceas insuline   Sigma-Aldrich, St.Louise, MO, USA 
Formalin     Sigma-Aldrich, St.Louise, MO, USA 
Red Oil O stock    Sigma-Aldrich, St.Louise, MO, USA 
Isopropanol 60%    Sigma-Aldrich, St.Louise, MO, USA 
beta-glycerophosphate disodium salt hydrate 
       Sigma-Aldrich, St.Louise, MO, USA 
L-ascorbic acid    Sigma-Aldrich, St.Louise, MO, USA 
Alizarin Red S     Sigma-Aldrich, St.Louise, MO, USA 
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Ammonium hydroxide solution  Sigma-Aldrich, St.Louise, MO, USA 
Ethanol 70%     Sigma-Aldrich, St.Louise, MO, USA 
Ethanol 95%     Sigma-Aldrich, St.Louise, MO, USA 
Xylene      Sigma-Aldrich, St.Louise, MO, USA 
Paraplast Paraffin    Leica, Wetzlar, Germany 
Hematoxylin Solution, Harris modified Sigma-Aldrich, St.Louise, MO, USA 
Ethanol 100%     Sigma-Aldrich, St.Louise, MO, USA 
Lithium carbonate    Sigma-Aldrich, St.Louise, MO, USA 
Eosin Y     Sigma-Aldrich, St.Louise, MO, USA 
Phloxine B     Sigma-Aldrich, St.Louise, MO, USA 
Acetic acid     Sigma-Aldrich, St.Louise, MO, USA 
Cytoseal mounting media   Thomas Scientific, Swedesboro, NJ, 
USA 
Mouse anti-rabbit monoclonal antibody-against Collagen-I   
       Abcam, Cambridge, England 
Goat anti-mouse IgG H&L (HRP)  Abcam, Cambridge, England 
Goat anti-mouse IgG H&L (Texas Red) Abcam, Cambridge, England 
Tris-EDTA buffer solution   Sigma-Aldrich, St.Louise, MO, USA 
Tween 20     Sigma-Aldrich, St.Louise, MO, USA 
Bovine serum albumin   Sigma-Aldrich, St.Louise, MO, USA 
Hydrogen peroxide 30%   Sigma-Aldrich, St.Louise, MO, USA 
Trisodium citrate dehydrate   Sigma-Aldrich, St.Louise, MO, USA 
Triton X     Sigma-Aldrich, St.Louise, MO, USA 
Sodium azide     Sigma-Aldrich, St.Louise, MO, USA 
Gelatin from cold water fish skin  Sigma-Aldrich, St.Louise, MO, USA 
3,3’-Diaminobenzidine   Sigma-Aldrich, St.Louise, MO, USA 
 
6.1.2 Equipment 
 
Autoclaving     Systec, Linden, Germany 
Vicryl 4-0     Ethicon, Somerville, New Jersey 
50 ml plastic pipette    Grainer bio-one, Kremsmünster, 
       Austria 
Shaker HS 501 digital   Ika Labortechnik, Staufen, Germany 
| 25 
50 ml plastic tube    Grainer bio-one, Kremsmünster, 
       Austria 
Centrifuge Multifuge 3S   Heraeus, Hanau, Germany 
100μm Steriflip    Merck Millipore, Billerica, MA, USA 
Collagen matrix (Puracol® Plus)  Medline Industries, IL, USA 
Fume hood M18    Schulz Lufttechnik, Sprockhövel, 
       Germany 
Olympus BX 40    Shinjuku, Tokio, Japan 
Polypropylene 2-0    Ethicon, Somerville, New Jersey 
T75 culture flask    Sarstedt, Nürnbrecht, Germany 
Incubator Hera Cell 240   Thermo Scientific, Waltham, MA, USA 
Inverted microscope Wilovert S  Helmut Hund GmbH, Wetzlar, 
       Germany 
Refrigerator Liebherr medline  Liebherr, Bulle, Schweiz 
6 well-plate cellstar    Grainer bio-one, Kremsmünster 
       Austria 
HM 400     Microm, Heidelberg 
Slides      Engelbrecht GmbH, Edermünde, 
       Germany 
Microscope Axiovert    Carl Zeiss AG, Oberkochen, Germany 
Camera Canon G7    Canon, Takio, Japan 
Sonoelastographic device LOGIQ®E9 General Electrics, Fairfield, CT, USA 
Multifrequency probe 6-15 MHz  General Electrics, Fairfield, CT, USA 
Counting chamber Neubauer-improved Paul Marienfeld GmbH, 
Lauda-Königshofen, Germany 
 
6.1.3 Software 
 
Real-time sonoelastography software General Electrics, Fairfield, CT, USA 
GraphPad Prism 5 for Windows  GraphPad Software Inc., La Jolla, CA, 
USA 
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6.2 Methods 
 
6.2.1 Preparation of the fat body 
 
A total of nine male New Zealand white rabbits weighing 3.5±0.5 kg were used 
to evaluate if sonoelastography is able to depict elastic recovery after 
autologous adipose-derived stem cell application on injured Achilles tendon 
following the guidelines of Veterinary Medicine & Surgery at MD Anderson 
Cancer Center and US National Institutes of Health. The study was approved by 
the IACUC of MD Anderson Cancer Center Houston. All the rabbits were aged 
14 to 16 weeks and were randomly assigned to either a control group without 
injury or a group treated with ASCs seeded collagen matrix or treated with 
unseeded collagen matrix. Equipment for all operations was sterilized by 
autoclaving at MD Anderson facility. All animals were anaesthetized by 
administration of isoflurane received by mask. Anesthesia was monitored by 
respiratory rate and heart rate, response to noxious stimulus, spontaneous 
movement, pedal reflex, oxygen saturation and body temperature. Each rabbit 
was placed in prone position for harvesting the nuchal fat body. The hair in the 
field of operation was shaved and the skin was surgically prepared using 
povidone iodine for disinfection. Subsequently, the animal was transferred to a 
heated surgery table and the nuchal region was covered with a sterile surgical 
drape. A small incision of 3 cm with a scalpel no. 15 was made to approach the 
rabbit’s nuchal fat body (Figure 2), which was excised bilaterally and transferred 
into a sterile container for stem cell harvesting. The mean weight of the fat 
bodies was 15±2.4 grams. The subcutaneous layer and the skin were closed by 
continuous suture technique with Vicryl 4-0. Every step was performed by using 
aseptic techniques. All animals received perioperative doses of prophylactic 
antibiotics (Cefazolin 15mg/kg, i.v.). 
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Figure 2: Nuchal adipose fat body that was used to harvest adipose tissue derived 
mesenchymal stem cells after surgical preparation. 
 
 
6.2.2 Stem cell isolation 
 
Nuchal fat tissue was extensively washed in PBS after harvesting and 
subsequently minced in pieces less than 1mm³. Subsequently, the minced 
tissue was incubated in PBS containing Blendzyme III (2U/mL) for 30 minutes at 
37°C on a shaker at 100 rpm. After digestion, the suspension was 
disaggregated by pipetting 5 times under sterile conditions and was transferred 
into a 50 ml plastic tube followed by centrifugation at 450g for 10 minutes 
(Figure 3). The supernatant was discarded and cells were washed twice with 
PBS. Afterwards, cells were vacuum filtered through a 100 μm Steriflip. The 
filtered cell suspension was then centrifuged at 450g for 10 minutes. The 
supernatant containing adipocytes and debris was discarded and the pelleted 
cells were washed twice with 40 ml Hanks Balanced Salt Solution. The pellet 
was resuspended in PBS for immediate application or for further in vitro 
experiments in alpha-MEM supplemented with 20% fetal bovine serum (FBS), 
100 U/ml penicillin and 100 µg/ml streptomycin. For immediate application cell 
number was determined using a Neubauer chamber. Subsequently, the 
suspension with the ASCs was seeded on a collagen matrix with 1x106 stem 
cells in 200µl PBS after labeling with DAPI. Except for digestion and 
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centrifugation all steps were performed under a fume hood to remain sterile 
conditions. 
 
Table 2. Preparation of 500 ml growth medium 
Reagents Amount 
FBS 
Glutamine 
Streptomycin 
Penicillin 
alpha MEM 
100 ml 
14,61 g (2 mM) 
50 mg 
50000 U 
Up to 500 ml 
  
 
 
 
Figure 3: 50 ml plastic tube after first centrifugation with 450 g for 10 minutes, fraction 6 
shows the stem cell pellet 
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6.2.3 DAPI labeling of ASCs and fluorescence microscopy 
 
Freshly isolated ASCs from the rabbit’s nuchal fat body were labeled with DAPI 
before seeded onto the collagen matrix. DAPI stock solution (Table 3) was 
diluted to final concentration of 50µg/ml in PBS and ASCs were incubated for 30 
minutes at 37°C. Afterwards, cells were centrifuged at 500g for 5 minutes, and 
resuspended in PBS to further seed onto the matrix. Final DAPI concentration 
was revealed by testing ascending concentration without inducing apoptosis in 
previous tests. 
 
For fluorescence microscopy 8 µm-thick sections were prepared from each 
tendon and 3 sections were microscoped to test for the presence of ASCs. 
Tissue sections were microscoped using 358 nm wavelength and emission filter 
of 461 nm. All stained slides for fluorescence microscopy were analyzed using a 
Olympus BX 40 microscope equipped with a Canon G7 high-resolution digital 
camera adapter for image acquisition. 
 
Table 3. Preparation of 100 ml DAPI working solution 
Reagents Amount 
DAPI stock solution 
PBS 
5000 µg 
Up to 100 ml 
  
 
6.2.4 Preparation of the Achilles tendon 
 
The hair of both hind limbs was shaved and the skin was disinfected with 
povidone iodine using aseptic techniques. Both hind limbs were covered with a 
steril surgical drape. Under aseptic conditions, a 3 cm small sharp skin incision 
was made with a scalpel no. 15 laterally to the Achilles tendon and the tendon 
was exposed. The peritendon was opened and the tendons of the musculus 
plantaris, soleus and gastrocnemius were identified and segmented (Figure 4a). 
Only the gastrocnemius tendon was transected with a scalpel blade 
perpendicular to the collagen fibers 3 cm above the tendon insertion of the 
calcaneus. A gap of 10 mm was created on each limb and the defect randomly 
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received either a collagen matrix (Puracol® Plus) with 1x106 stem cells (group 
2, n=6 tendons) suspended in 200µl PBS or without stem cells (group 3, n=6 
tendons). Collagen matrix was sutured in place using a modified Kessler pattern 
with 2-0 polypropylene. Control animals received no injury (group 1, n=6 
tendons) but were sham operated. Skin was closed by suture using 4-0 Vicryl. 
The leg was bandaged and postoperative analgesia were accomplished with 
Buprenex 0.5-2.5 mg/kg s.c./i.m. and Meloxicam (0.2 mg/kg, i.m. first day 
followed by 0.1 mg/kg once per day) or Fentanyl citrate. The rabbits were not 
immobilized postoperatively and were fed ad libitum. In a preliminary study we 
established the operation technique which provides enough movement of the 
animals to access food and water due to intact soleus and plantaris tendon. 
During the postoperative time, clinical parameters including activity, infection, 
bleeding, appetite and wound dehiscence were evaluated daily. All nine animals 
were anesthetized by isoflurane and sacrificed by an overdose of Buthanasia 
solution 8 weeks after tendon surgery to remove the whole tendons for 
sonoelastographical examination (Figure 4b). For harvesting the specimens, the 
calcaneus with Achilles tendon was displaced and the gastrocnemius muscle 
was transected. Tendons were packed in moist saline dressings, frozen and 
stored at -20°C. For sonoelastography tendon were slowly thawed over night in 
a refrigerator at 4°. One hour prior to the experiment tendons were equilibrate at 
room temperature and kept moist by saline solution. Tendons were fixed by pins 
on a cork board without tension. All sonoelastographic measurements were 
performed on the same day.  
         
 
Figure 4: After gastrocnemius tendon dissection insertion of the collagen matrix and 
fixation with a modified Kessler suture technique (a). Scar formation of Achilles tendon 
after 8 weeks of gastrocnemius tendon dissection (b). 
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6.2.5 Expansion and subculturing of ASCs 
 
The cell pellet was resuspended after isolation in complete growth medium 
consisting of alpha-MEM, 20 % FBS, 2 mM L-glutamine, 100 U/ml penicillin and 
100 μg/ml streptomycin. Plastic adherent ASCs were grown in appropriate cell 
culture flasks and placed in an incubator at 37 °C in a humidified atmosphere 
containing 5 % CO2. Daily washings on the first 2 days removed nonattached 
cells. Growth medium was exchange twice a week until 90 % confluency. Cell 
culture was examined daily under an inverted microscope. After reaching 90% 
confluency the medium was discarded and cells were washed twice with PBS. 
Trypsin was added (1ml for a T75 flask) and incubated for 3 minutes at 37°C in 
a humidified atmosphere containing 5 % CO2. Subsequently, the effect of 
trypsin was neutralized by adding growth medium. Cells were centrifuged at 
500g for 5 minutes, resuspended in growth medium and splitted 1:3 for 
subculturing.  
 
Table 4. Preparation of 500 ml growth medium 
Reagents Amount 
FBS 
Glutamine 
Streptomycin 
Penicillin 
alpha MEM 
100 ml 
14,61 g (2 mM) 
50 mg 
50000 U 
Up to 500 ml 
  
 
 
6.2.6 Adipogenic differentiation of ASCs  
 
Plastic adherent ASCs were washed twice with PBS and trypsinized by 0.25% 
trypsin. Cells were seeded into 6 well-plates at a concentration of 1.5x104 cells 
per cm² and adipogenic differentiation was induced by differentiation medium 
consisting of growth media (Table 4) with 0.5 mM Isobutyl-methylxanthine, 10 
μM bovine insulin, 1 μM dexamathasone and 200 μM indomethacin (Table 
5).The medium was changed every 3 days whereas only ASCs in passage 
below 5 were used for adipogenic assay to ensure efficient differentiation. ASCs 
were exposed to adipogenic induction media for a period of 14 days.  
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Table 5. Preperation of 100 ml adipogenic differentiation 
medium 
Reagents Amount 
Dexamethasone 
Isobutyl-methylxanthine 
Bovine insulin 
Indomethacin 
Growth medium 
39,2 µg (1 µM) 
11,21 mg (0,5 mM) 
5,78 mg (10 µM) 
7,16 mg (200 µM) 
Up to 100 ml 
  
 
Adipogenic transdifferentiation was detected by Oil Red O staining which 
detects intracellular oil droplets, triglycerides respectively. Oil Red O working 
solution was prepared by 6 parts of Oil Red O working solution and 4 parts of 
distilled water (Table 6). Induction medium was discarded and cells were fixed 
with 4% formalin for 5 minutes at room temperature. Formalin was discarded 
and fresh formalin was added for an incubation of 60 minutes. Afterwards 
formalin was removed and cells were washed with 60% isopropanol. Oil Red O 
working solution was added and incubated for 10 minutes followed by washing 
four times with distilled water. Finally 4 ml of distilled water was added to 
prevent the cells from drying. 
 
Table 6. Preperation of 100 ml Oil Red O Working 
Solution 
Reagents Amount 
Oil Red O stock 
 
dH2O 
60 ml (0,21 g Oil Red 
O) 
40 ml 
  
 
 
6.2.7 Osteogenic differention of ASCs 
 
Plastic adherent ASCs were washed twice with PBS and trypsinized by 0.25% 
trypsin. Cells were seeded into 6 well-plates at a concentration of 1.0x104 cells 
per cm² and osteogenic differentiation was induced by differentiation medium 
consisting of Growth media (Table 4) with 10 mM beta-glycerophosphate 
disodium salt hydrate , 50 μM L-ascorbic acid, and 100 nM dexamethasone 
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(Table 7). The medium was changed every 3 days whereas only ASCs in 
passage below 5 were used for osteogenic assay to ensure efficient 
differentiation. ASCs were exposed to osteogenic induction media for a period 
of 14 days. 
 
Table 7. Preparation of 100 ml osteogenic differentiation 
medium 
Reagents Amount 
Dexamethasone 
L-ascorbic acid 
Beta-glycerophosphate 
disodium salt hydrate 
Growth medium 
3,92 µg (100nM) 
0,881 mg (50 µM) 
0,461 g (10mM) 
 
 Up to 100 ml 
  
 
Osteogenic transdifferentiation was detected by Alizarin Red S staining which 
detects osteocytes’ calcium deposits. Alizarin Red solution was prepared of 2g 
Alizarin Red with 100 ml of distilled water (Table 8). The pH-value was adjusted 
to 4,1-4,3 with ammonium hydroxide solution. Induction medium was discarded 
and cells were fixed by incubating in iced cold 70% ethanol for 60 minutes at 
room temperature. Ethanol was discarded and cells were rinsed twice for 5 
minutes with distilled water. Afterwards 5 ml of the Alizarin Red S solution was 
added and incubated for 30 minutes at room temperature. Alizarin Red S 
solution was removed and each well was washed four times with distilled water. 
Finally 4 ml of distilled water was added to prevent the cells from drying. 
 
Table 8. Preparation of 100 ml Alizarin Red S Solution 
Reagents Amount 
Alizarin Red S 
dH2O 
ammonium hydroxide solution 
2 g 
Up to 100 (50 µM) 
up to pH 4,1-4,3 
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6.2.8 Histology 
 
After sonoelastography tendon tissue was immediately washed extensively with 
PBS to removed remaining ultrasound gel and placed in 4% formalin for 24 
hours followed by ascending ethanol series starting at 70% for 60 minutes 
followed by 95% ethanol for 60 minutes, first 100% ethanol for 60 minutes, 
second 100% ethanol for 90 minutes, third 100% ethanol for 90 minutes and 
fourth 100% ethanol for 120 minutes. Next the tendons were processed twice 
with xylene as clearing agent for 60 minutes each. Ethanol and xylene were 
replaced with fresh reagents after every use. Fixed tissue specimens were 
embedded in paraffin wax for 60 minutes at 58°C. 3 μm serial sectioning of 
paraffin-embedded specimen blocks was performed with a HM 400. For 
histology 3 μm slides were deparaffinized by 2 changes of xylene for 10 minutes 
each and rehydrated in 2 changes of absolute ethanol for 5 minutes each, 95% 
ethanol for 2 minutes and 70% ethanol for 2 minutes followed by rinsing in 
distilled water for 5 minutes.  
Tissue sections were stained in hematoxylin (Table 13) solution for 6 minutes 
and rinsed for 20 minutes in tap water. Afterwards, slides were decolorized in 
acid alcohol (Table 12) for 1 second followed by rinsing again for 5 minutes in 
tap water. Next specimens were immersed in lithium carbonate (Table 14) for 3 
seconds, rinsed in tap water for 5 minutes and counterstained in eosin solution 
(Table 9) for 15 seconds. Stained specimens were dehydrated with 2 changes 
of 95% ethanol for 3 minutes and 2 changes of 100% ethanol for 3 minutes. 
Specimens were cleared in 2 changes of xylene for 5 minutes each. Ethanol 
and xylene was discarded after each use. Finally the stained specimens were 
mounted with cytoseal in a fume hood.  
 
Table 9. Preparation of working solution eosin 
Reagents Amount 
Eosin stock 
Phloxine B stock solution 
95% ethanol 
Acetic acid 
100 ml 
10 ml 
780 ml 
4 ml 
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Table 10. Preparation of eosin stock solution 
Reagents Amount 
Eosin Y 
dH20 
1 g 
100 ml 
  
 
Table 11. Preparation of phloxine B stock solution 
Reagents Amount 
Phloxine B 
dH2O 
1 g 
100 ml 
  
 
Table 12. Preparation of 0,25% working solution acid 
alcohol 
Reagents Amount 
95% ethanol 
dH2O 
HCL 
2578 ml 
950 ml 
9 ml 
  
 
Table 13. Preparation of Working solution hematoxylin 
Reagents Amount 
Hematoxylin Solution, Harris 
modified 
1 L 
  
 
Table 14. Preparation of working solution lithium 
carbonate 
Reagents Amount 
Lithium carbonate 
dH2O 
47 g 
3500 ml 
  
 
A series of 3 μm-thick sections were utilized for immunohistochemical staining. 
A mouse anti-rabbit monoclonal antibody against collagen I was used to detect 
the expression of collagen I in Achilles tendon tissue. For pretreatment heat-
induced retrieval was conducted to break the methylene bridges, formed during 
fixation, to expose antigenic sites in order to allow the antibodies to bind. 
Therefore antigen retrieval buffer (Tris-EDTA) was added to a pressure cooker 
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that was placed on a hotplate. Once boiling, the slides, placed in a metal rack, 
were transferred to the pressure cooker. Lid was secured and as soon as full 
pressure was reached, slides were processed for further 3 minutes. When time 
was elapsed pressure cooker was placed in an empty sink and pressure was 
released while cooling down in running tap water. Once depressurized lid was 
opened cold running water was applied into the pressure cooker for 10 minutes. 
Next, pretreated slides underwent the staining procedure. First every slide was 
rinsed with 2 changes of PBS-Tween 20 (Table 17) for 2 minutes and then 
incubated in universal blocking buffer (Table 16) for 120 minutes at room 
temperature. Slides were rinsed in PBS Tween-20 before applying the mouse 
anti-rabbit monoclonal antibodies against collagen I diluted 1/200 in antibody 
dilution buffer (Table 18) for incubation at 4°C overnight. Next, slides were 
again rinsed with PBS-Tween 20 and incubated in 0.3% peroxidase in PBS 
blocking solution (Table 15) for 15 minutes at room temperature. After rinsing 
with PBS-Tween 20, slides were incubated with the secondary goat anti mouse 
HRP conjugated antibody diluted 1/500 in antibody dilution buffer for 1 hour at 
room temperature. Working solution of DAB was applied to tissue section for 10 
minutes and monitored for chromogenic reaction. Slides were washed twice 
with distilled water for 2 minutes each followed by dehydration, clearing and 
mounting as described above. All stained slides were analyzed using an 
Axiovert microscope equipped with a Canon G7 high-resolution digital camera 
for image acquisition. For fluorescence histology a Texas Red conjugated goat 
anti-mouse antibody was used as secondary antibody. All steps of staining, 
except of the application of DAB, were performed in the same way. For 
analyzing the slides microscopy was performed in the dark using 586nm 
wavelength and an emission filter of 605 nm. 
 
Table 15. Preparation of peroxidase blocking solution 
Reagents Amount 
30% Hydrogen peroxide 
PBS 
10 ml 
990 ml 
 
  
| 37 
 
Table 16. Preparation of 100 ml universal blocking buffer 
Reagents Amount 
BSA 
Cold fish skin gelatin 
Triton X-100 
Sodium azide 
PBS 
1 ml 
0,1 ml 
0,5 ml 
0,05 ml 
up to 100 ml 
 
Table 17. Preparation of PBS-Tween 20 
Reagents Amount 
PBS 
Tween 20 
95 ml 
5 ml 
 
Table 18. Preparation of 100 ml antibody dilution buffer 
Reagents Amount 
BSA 
PBS 
1 ml 
99 ml 
 
 
6.2.9 Sonoelastography 
 
The experimental set-up included a LOGIQ®E9 (General Electrics) (Figure 5, 6) 
using a linear high resolution multifrequency probe from 6-15 MHz (Figure 7). 
The same conditions of brightness, contrast, intensity, color scale and 
frequency were used in all examinations. All measurements were performed by 
one experienced examiner (more than 5000 examinations per year). First an 
examination with the fundamental B-scan was performed in the longitudinal 
plane of the Achilles tendon to localize a potential irregularity of the tendon after 
the earlier disruption or as the development of the repair mechanism. Then the 
color coded ultrasound elastography was performed for whole tendon tissue up 
to a distance from 4 cm in the longitudinal plane and 5 mm in the axial plane. 
The probe was perpendicular to the tendon in order to avoid anisotropy. The 
aim was to find changes of the color coded evaluated tissue elasticitiy in relation 
to surrounding normal tissue (red colour), tissue with good elasticity (yellow 
colour), particularly fibrosis (green colour), or a scar (blue colour).  For each 
tendon real-time color-coded sonoelastography sequences of 20 seconds were 
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recorded. A quality marker was used to evaluate the best compression mode. 
Only sequences with the highest image quality with five green points were used 
for an appositional evaluation by a quantification mode (Q-analysis) integrated 
in the ultrasound machine workstation. Ten color histogram frames were 
obtained for each tendon at ten randomly chosen time-points. Regions of 
interest (ROIs) were placed on the defect (n=3) and on adjacent uninjured 
tendon tissue. Real-time sonoelastography software calculated tendon’s 
elasticity in the region of interest by depicting certain local tissue displacement 
during a time shift in a certain color. A quantified value was assigned to each 
color, which serves as the elasticity index (EI) and ranges from 0.0 to 6.0. 
Higher values represent higher stiffness and are visualized by a dominant blue 
color. This provides more objective information about the elasticity. Elasticity of 
the specimen was reconstructed by calculation of tissue displacement using the 
elastogram as a color overlay superimposed on the B-mode ultrasound image. 
A visual indicator on the screen displayed ongoing tissue compression to 
assure correct technique of compression and decompression applied to the 
tendon. All tendons were covered with ultrasound gel for a longitudinal 
examination (Figure 8). 
A total of 180 measurements were obtained and mean intensity of color 
histograms were computed by a novel customized GE software. Ten time-point 
measurements ensured that EI was not affected by compression variances 
caused by the examiner. All of these images were recorded on a hard disk and 
used for statistical evaluation. 
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Figure 5: LOGIQ®E9 (General Electrics) 
 
  
Figure 6: Experimental set up including a LOGIQ®E9  
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Figure 7: Linear high resolution multifrequency probe from 6-15 MHz during 
examination 
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Figure 8: Achilles tendon covered in ultrasound gel before examination 
 
 
6.2.10 Statistical analyses 
 
Statistics were calculated using GraphPad Prism 5 for Windows. Results are 
shown as means ± standard deviation. All data sets of metric variables were 
checked for Gaussian distribution (Kolmogorov-Smirnov test, alpha = 5 %).  
Continuous variables were compared by means of one-way ANOVA with 
Scheffe post hoc correction. Differences between the ten time-points for 
sonoelastographic measurements were examined by repeated measures 
ANOVA with a Greenhouse-Geisser correction since assumption of sphericity 
had been violated (Mauchly's Test of Sphericity p < 0.0001). Values at p < 0.05 
were considered as statistically significant. 
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7. Results 
 
7.1 ASC preparation and injection 
 
Nuchal adipose tissue was successfully harvested from all animals followed by 
enzymatic digestion in order to extract mesenchymal stem cells. Mean weight of 
harvested nuchal fat tissue was 15 g ± 2.4 g. Skin incisions healed without 
complications or defects in all rabbits. All cells were processed as described 
above and total yield of freshly isolated cells ranged from 27.5 x 106 to 31.3 
x106 cells with a cell viability of 91%±3.2%. During the postoperative time, 
clinical parameters including activity, infection, bleeding, appetite and wound 
dehiscence were observed without any complications or irregularities.  
 
 
7.2 Transdifferentiation of ASCs 
 
7.2.1 Adipogenesis 
 
Adipose derived stem cells of rabbits nuchal fat tissue were treated with 
adipogenic differentiation medium and showed differentiation into adipocytes. 
Differentiated stem cells contained Oil Red O-positive lipid vacuoles 
(triglyceride) clustered within cytoplasma after 14 days of adipogenesis (Figure 
9a). A negative control, receiving growth medium instead of adipogenic 
differentiation medium, did not show any Oil Red O positive lipid vacuoles 
(Figure 9b). 
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Figure 9: (a) Adipogenic differentiation of ASCs after 14 days of incubation with 
adipogenic differentiation medium, stained with Oil Red O. (b) negative control of ASCs 
incubated with growth medium for 14 days, also stained with Oil Red O 
 
 
7.2.2 Osteogenesis 
 
Treatment of adipose derived stem cells from the nuchal fat tissue with 
osteogenic differentiation medium resulted in a differentiation of ASCs into 
osteocytes. Successfully differentiated stem cells produced Alizarin Red S-
positive nodules of mineralized calcium phosphate matrix above the cell 
monolayer after 14 days of osteogenesis (Figure 10a). A negative control, 
receiving growth medium instead of osteogenic differentiation medium, did not 
show any Alizarin Red S-positive nodules (Figure 10b). 
 
 
Figure 10: (a) Osteogenic differentiation of ASCs after 14 days of incubation with 
osteogenic differentiation medium, stained with Alizarin Red, (b) negative control of 
ASCs incubated with growth medium for 14 days, also stained with Alizarin Red 
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7.3 Effects of ASCs on tendon’s elasticity 
 
Real time sonoelastography was performed in order to characterize the 
elasticity of Achilles tendons. Elasticity index (EI) was calculated from regions of 
interest, which were placed on injured (n=3) and non-injured (n=3) tissue on 
each tendon. The mean EI from Achilles tendons without injury (group 1), 
injured achilles tendons with ASC seeded matrix (group 2) and injured tendons 
with unseeded matrix (group 3) were compared to evaluate the effect of applied 
stem cells. 
Post hoc tests using the Scheffe correction revealed a higher elasticity, 
measured by EI for the injured tendon tissue treated with ASC seeded matrix 
(group 2, Figure 11a) in comparison to the unseeded matrix (group 3, Figure 
11b) (0.73±0.26 and 4.02±1.33, respectively; p<0.01; Figure 11c). 
In addition, no difference was found between the injured tendon tissue treated 
with ASC seeded matrix (group 2) and the uninjured Achilles tendons (group 1) 
(0.73±0.26 and 1.05±0.40, respectively; p>0.05). 
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Figure 11: Example of sonoelastography for injured tendon tissue treated with stem cell 
seeded matrix (a) and unseeded matrix (b). Statistical analysis (c) revealed that 
autologous ASC treatment significantly lowered (**p<0,001) elasticity index of Achilles 
tendons (0.73, SD±0.26) compared to tendons treated with unseeded matrix (4.02, 
SD±1.33) but did not differ (n.s., p>0.05) from uninjured tendons (1.05, SD±0.40).  
  
| 46 
Repeated measures ANOVA with a Greenhouse-Geisser correction for each 
tendon group demonstrated no difference in EI measurements between all ten 
time points (p>0.05) (Figure 12) indicating a reproducible procedure with valid 
data inquiry. 
 
Figure 12: A repeated measures ANOVA for each tendon group determined that EI did 
not differ statistically significantly (p>0.05) between all ten time points (1-10) in each 
group. This demonstrates that tendon compression during elastographic measurement 
for each group gives reliable results independent of the time. Standard deviation of 
tendons treated with unseeded matrix (SD±1.33) were significantly higher (p<0.01) 
when compared to uninjured (SD±0.40) or ASC seeded matrix treated tendon tissue 
(SD±0.26).  
 
Furthermore, the standard deviation of the elasticity index between uninjured 
tendons (SD±0.40) and stem cell treated tendons (SD±0.26) did not show a 
significant difference (p>0.05). Interestingly, standard deviation of tendons 
treated with unseeded matrix (SD±1.33) was significantly higher (p<0.01) when 
compared to uninjured or ASC seeded matrix treated tendon tissue. 
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7.4 Fluorescence microscopy 
 
Fluorescence microscopy was performed for each tendon treated with DAPI 
labeled ASCs. All tissue sections were positive for labeled ASCs whereas no 
cells were apparent in adjacent tissue. Even after 8 weeks DAPI labeled cells 
were detected and showed successful engraftment after local application 
(Figure 13). In preliminary examination apoptosis and cytotoxicity was 
recognized as acceptable for a DAPI-concentration of 50µg/ml. 
In the surrounding of ASCs Texas Red labeled collagen I could be detected 
(Figure 14). 
 
Figure 13: Overlay of phase-contrast and fluorescence microscopy of tendon tissue 
section 8 weeks after implantation. ASCs are labeled with DAPI and can be found 
throughout the tissue section.  
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Figure 14: Fluorescence microscopy of tendon tissue section with DAPI labeled ASCs 
and Texas Red labeled collagen I antibody.  
 
 
7.5 Histological examination 
 
Histological examination of tendon tissue was performed 8 weeks after initial 
injury and demonstrated organized bands of collagen in both matrix treated 
groups and non-injured tendon tissue. No differences were observed regarding 
elongated cell morphology and parallel organization between groups treated 
with extracellular matrix seeded with stem cells (group 2) or without (group 3) 
(Figure 16). Moreover, no differences were apparent for Collagen I content 
between all groups (Figure 15). 
 
 
Figure 15: Immunohistochemistry of collagen I of (a) the control group (no injury) (b) 
matrix only (c) ASCs seeded matrix; (all 4x magnification) 
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Figure 16: H&E staining of (a) the control group (10x magnification), (b) matrix only (5x 
magnification), (c) ASCs seeded matrix (4x magnification) 
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8. Discussion 
 
The aim of the study was to investigate the effect of adipose-derived stem cells 
on tendon’s elasticity and the capability of real time sonoelastographic 
examination to monitor tendon elasticity. 
 
 
The major finding of the present study is that adipose derived stem cells 
embedded in extracellular collagen matrix have the capability to restore 
tendon’s elasticity significantly after injury to the same level of uninjured tendon 
tissue. Furthermore, sonoelastography proved to be a valuable tool to monitor 
elasticity of Achilles tendon during tendon tissue regeneration. 
In addition, sonoelastography is able to monitor the elastic properties of tendons 
in an examiner-independent and reproducible manner 
 
 
Transdifferentiation of ASCs 
 
The present study demonstrated that ASCs, yield from the same fat body as 
ASCs seeded on the collagen matrix, have the capability to differentiate into 
adipocytes and osteocytes in vitro.  
These findings are consistent with previous studies showing that ASCs are able 
to retain the ability to differentiate into cell types of multiple different lineages 
like adipocyte, chondrocyte, myocyte, neuronal and osteoblast lineages66. 
Recently, Uysal et al.47 demonstrated that ASCs differentiate into tenocytes in-
vivo and pointed out that this finding might be a direct effect of applied ASCs to 
tendon healing. However, control and secretion of growth factors in the 
environmental tissue may also play a substantial role during primary tendon 
repair .This is supported by findings that ASCs are able to express tendon 
specific markers when treated with growth differentiation factor 5 67. 
The cellular constructs may have had different mechanical and physical 
properties as compared to the acellular constructs due to the applied cells 
which have caused differences in local microenvironment response. 
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The treatment of collagen composites with ASCs showed a significant higher 
elasticity than tissue repair without cells. However, this improvement did not 
correlate with cell morphology or parallel collagen organization in histological 
examination. Moreover, no differences were apparent for investigated Collagen 
content. This is in line with a previous study that investigated different stem cell 
densities on collagen matrices on a rabbit patellar tendon defect49. However, to 
date it is still under investigation whether cell differentiation of ASCs into 
tenocytes or growth factors expressed by ASCs is crucial for tendon tissue 
repair. 
 
Sonoelastography and elasticity 
 
The purpose of rehabilitation after tendon injury is to restore optimal tendon 
function, which requires re-establishment of tendon fibers and gliding 
mechanisms between tendon and its surrounding structures68 while 
simultaneously preventing tendon rupture69 as the most common complication 
during rehabilitation70. This is hindered by the limited self-repair capacity of 
tendon tissue, which is especially due to its cell-poor composition, its 
bradytrophic nature10 and a low metabolic rate11 which results in slow healing 
after injury. After tendon injury the formation of scar tissue occurs due to the 
proliferation phase in which synthesis of collagen III peaks71 followed by the 
remodeling phase commencing with a higher proportion of synthesis of 
stronger72 collagen I73. This is why the strength of the immature scar tissue from 
the proliferation phase increases during the remodeling phase. 11 weeks after 
tendon tissue injury a stepwise change of the fibrous tissue to scar-like tendon 
tissue occurs and last over the period of up to one year74 during  the maturation 
stage. Nevertheless ruptured tendon in its natural composition never regains 
the biomechanical properties prior to injury75. This scar-like tissue could be one 
reason of less elasticity in complete ruptured Achilles tendons as reported by 
Tan S. et. al.64. 
Not only stiffness and elasticity, respectively, or tendon’s composite are 
parameters for tendon’s mechanical function but also ultimate load, ultimate 
strain and tensile strength16 . Alteration of these parameters, naturally evolve 
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during the process of aging, account for tendons susceptibility to tear when 
exposed to increasing stress76. 
To demonstrate efficient tendon regeneration regarding force transmission 
various studies have been investigated dynamic and static biomechanical 
properties77, histological differences78, ultimate load and stiffness79, cross link 
density80, collagen composition81 and correlation of force with fibril diameter82. 
However, all described methods, evaluating indicators for tendon healing, are 
inapplicable for in vivo use and therefore are not suitable for clinical purposes. 
Moreover, preparation of histologic sections requires several days to weeks and 
includes animal-to-animal variations when making a static histologic 
assessment. In addition, recent studies suggest that histological changes might 
not be significant for time points after 6 weeks post-surgery10,49. These results 
stand in line with outcomes of this study as almost no differences could be 
determined between ASCs treated tendons, tendons without ASCs and 
uninjured tendons in the histological examination. This finding may indicate 
tendon’s elasticity cannot be evaluated by histological examination and 
therefore other methods have to be used to provide a reliable source to monitor 
tendon regeneration or/and healing, especially for in vivo use. 
Sonoelastography enables the evaluation of tendons’ elasticity as a surrogate 
marker in vivo64,83, as well as for other types of tissue. Thus, sonoelastography 
is already in clinical use for the evalutation of tumor morphology (e.g. breast, 
pancreas, prostate, thyroid), tissue stiffness, (e.g. liver fibrosis), and 
characterization of soft tissue lesion.59–62,84–90 Studies support that although 
sonoelastography is not as established as ultrasound, it already offers a more 
precise localization of prostate carcinoma90. Moreover, studies reported an 
increased rate of detection for malignant thyroid nodules88 and provided 
evidence that SE is superior to ultrasound in evaluating pancreatic masses60. 
Conventional ultrasound can be used as a diagnostic tool in the postoperative 
assessment of the ruptured Achilles tendon91,92. The round irregular area with 
mixed echogenicity as well as the increased size of the operated Achilles 
tendon rupture is well detected by ultrasound93. This correlates with the 
ultrasound examination of the present study as ultrasound could depict the 
former defect in all injured tendons.  
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In the present study each tendon group demonstrates equal EI measurements 
between all ten time points which suggests sonoelastography is not only 
suitable to monitor elasticity of Achilles tendon, which stand in line with other 
studies64,83,94, but is able to do so in a reproducible, examiner-independent way, 
using the LOGIQ®E9 (General Electrics) software. Furthermore, this showed 
that the EI in the ROI is not affected by duration of pressure performed during 
the examination procedure. A major limitation of previous studies64,95,96 is based 
on the interpretation and description of pattern and scores which required 
radiologist’s experience. Furthermore, the evaluated elasticity in this present 
study was converted into a numerical value accurate to a tenth, using the 
LOGIQ®E9 (General Electrics) software, whereas other studies evaluated 
elasticity by a color grading system64,83,96, differentiating only between 3 grades. 
The LOGIQ®E9 software not only provides reproducible but also more precise 
results compared to former studies. To achieve the most reproducible and 
precise outcome a region of interest was placed at the site of the defect. This is 
of great necessity, especially in the group without injury, since even the same 
tendon may show different stiffnesses at different anatomic locations54. Further 
studies have to examine Achilles tendon in vivo using the LOGIQ®E9 (General 
Electrics) software to confirm the present results collected in ex vivo 
examination.  
Moreover, the EI of ASCs treated tendons was similar to the EI of uninjured 
tendons whereas EI for the collagen matrix alone treated tendons showed a 
much higher EI. This fact may indicate that real-time sonoelastography is 
suitable for the investigation of the healing process of the Achilles tendon since 
elasticity is an important function of tendon tissue54. In addition, this finding may 
further consider that a lower value of EI may reflect an improvement of the 
remodeling process with a decrease of scar-tissue. This is of interest since 
histological examination could not depict a clear difference regarding the size of 
scar tissue. Noteworthy, tendon elasticity has been reported to be correlated 
with late functional outcome in early stage of healing after injury97. 
Further investigation is needed to confirm whether sonoelastography is capable 
to monitor elasticity of tendons other than the Achilles tendon in the same 
reproducible and precise way. 
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Adipose derived stem cells and elasticity 
 
Primary tendon repair aims to increase tensile strength and other biomechanical 
parameters for early mobilization and prevention of re-rupture. Therefore open 
and percutaneous suture techniques as well as operation techniques have been 
investigated 98,99. Various authors have described modified suture techniques to 
increase the strength of primary repair100,101. In addition, stem cell application 
and matrix/scaffold implantation became a further approach to tendon repair by 
taking maximal advantage of natural healing processes. 
In the present study adipose derived stem cells were yield from nuchal fat tissue 
and were seeded onto collagen matrixes. Histological no significant difference 
of elongated cell morphology and parallel organization of collagen between both 
matrix treated groups regarding stem cell application was detected. Moreover, 
no differences for the collagen I content were apparent. These results suggest 
that tendon’s elasticity cannot be evaluated by histological examination due to 
almost similar properties after 8 weeks in all groups. The histological findings 
are in line with a previous report that showed no significant difference in cellular 
organization or histological appearance in a patellar tendon injury model at 6, 
12 or 26 weeks after surgery49. However, bone marrow derived stem cells 
treated matrix were used and compared with natural healing for this study. 
Noteworthy, it has been demonstrated that biomechanical properties increased 
at a significantly faster rate for stem cell treated tendon tissue. Interestingly, 
Chong et. al.37 could show that histomorphological differences, using bone 
marrow derived stem cells, were present only in time-points earlier than 6 
weeks after injury. In contrast, Young et. al. reported more elongated cell 
morphology and parallel organization in stem cell-loaded matrix in Achilles 
tendon injury, however, controls were only treated with suture40. These findings 
suggest, that the applied matrix in a tendon repair model has a significant 
impact on histological appearance and has to be considered as an additional 
supportive effect regarding organization of extracellular compounds. On the 
other hand, Nixon et al. showed that solely the injection of stem cells improved 
linearity of collagen fibers and uniformity appearances in histological section 
when compared to PBS injection102. However, this study used collagenase I to 
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induce a tendinitis rather than an incision injury which might be the main reason 
for reported results.  
Furthermore, the present study confirms that stem cell application successfully 
restores elastic properties of injured tendons (EI: 0.73, SD±0.26). Interestingly, 
elastic properties reached the same level as uninjured tendons (EI: 1.05, 
SD±0.40), whereas tendons treated with matrix only showed a significant higher 
EI (4.02, SD±1.33) when examined with LOGIQ®E9 (General Electrics) 
software. Tendon elasticity is one important marker regarding tendons 
biomechanical properties and is connected with tensile strength. Thus, the 
present results are supported by previous studies which showed an 
improvement of biomechanical properties due to mesenchymal stem cell 
application35,40,49. Uysal et al.16 could show that ASCs, in particular, mixed with 
platelet-rich plasma improves tensile strength when placed between the defect. 
A recently published study could show that even an intra-tendinous injection of 
adipose derived stromal vascular fraction is able to increase biomechanical 
properties51. Moreover, a number of studies40,103 have confirmed that scaffolds 
seeded with stem cells have better biomechanical properties than the 
implantation of constructs alone. These findings confirm the present results 
since tendons treated with matrix alone showed a much higher EI indicating a 
decrease of biomechanical property regarding elasticity. 
Furthermore, the standard deviation of the elasticity index between the group of 
uninjured tendons (SD±0.40) and the group of stem cell treated tendons 
(SD±0.26) did not show a significant difference (p>0.05). Interestingly, standard 
deviation of tendons treated with unseeded matrix (SD±1.33) were significantly 
higher (p<0.01) when compared to uninjured or ASC seeded matrix treated 
tendon tissue. This might demonstrate a more precise predictive power for the 
outcome of elasticity after treating achilles tendon ruptures with ASC seeded 
matrix in comparison with unseeded matrix. Moreover, this suggests that 
applied ASCs minimize the risk of outliners, which in part is giving rise to a re-
rupture rate after natural healing in human and other complications (e.g. longer 
rehabilitation time). This is of special interest, since histological investigation did 
not reveal any significant difference between both matrix groups. 
The present fluorescence microscopic examination for the detection of DAPI-
labeled ASCs revealed the presents of these cells in the area of defect at 8 
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weeks postoperatively whereas the labeled cells did not migrate into adjacent 
regions. This result is in line with a previous study using bone marrow derived 
stem cells49. The present results demonstrate that ASCs are able to integrate 
into an existing surrounding of united cell structure. ASCs can be applied easily 
to a tendon defect in a one-time procedure with improvement of elastic 
properties 8 weeks after surgery. The application of ASCs might be interesting 
for future consideration of Achilles tendon injury treatment since the early phase 
of tendon healing may predict the final outcome regarding elasticity97. 
Collagen type I synthesis is the key step in the determination of the tensile 
strength16. However, collagen type III initiates the healing process of tendons 
supplied by tenocytes and fibroblasts104. It was also shown that an increase of 
the collagen III content caused thinner collagen fibers and decreased the tensile 
strength at the same time6. Tang et al.105 described an increase of collagen I 
gene expression at later periods of tendon healing in vivo than the expression of 
the collagen III gene. Most important it was revealed that ASCs mixed with 
platelet-rich plasma increases the amount of collagen I when compared to the 
control group treated with platelet-rich plasma alone16. In view of these facts 
further research will be necessary to prove the influence of ASCs on the content 
of collagen I and III regarding to elasticity. Therefore histology of different time 
points and, above all, a control group treated neither with ASCs nor with 
collagen matrix alone would be helpful as the present study only investigated 
the differences of two matrix treated groups at one time point. The fact that in 
this particular situation no correlation between elasticity and the content of 
collagen I could be demonstrated suggests that there will no correlation at any 
different time point. Nevertheless the development of collagen I in an untreated 
control group and its elasticity seems to be very interesting when compared with 
the other groups. 
Moreover, histological examination at different time points of all groups would 
also be interesting for the questions whether DAPI-label ASCs stay at the same 
number or decrease. Concerning this matter Awad et al. showed that the 
intensity of fluorescence decreased with time after surgery, as did the number 
of stained bone marrow derived stem cells49. However, fluorescent cells were 
still apparent at the repair site at 26 weeks after surgery. 
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Further investigation will be necessary to show whether the density of applied 
ASCs to collagen matrix will affect elasticity or histological properties in any 
way. It was shown that different autologous mesenchymal stem cell 
concentrations (1, 4 and 8×106 cells/ml) in a type I collagen gel significantly 
improved tendon repair, but not in a dose-dependent manner49. Other authors 
showed that decreasing cell-to-collagen ratio by 20 times (from 0.8 to 0.04 M 
cells/mg collagen) improves cell viability in culture and improves biomechanics 
and histological appearance at 12 weeks postsurgery106. 
Ouyang and colleagues107 found that poly-lactideco-glycolide (PLGA) was 
better compared to other synthetic biodegradable polymers in allowing MSCs to 
adhere and grow. Furthermore, they demonstrated that the structure and 
biomechanic properties of tendon repair in a rabbit Achilles tendon model was 
improved by the composite of bone marrow stromal cells and knitted PLGA 
scaffold35. Kryger et al.108 performed in vivo and in vitro experiments to evaluate 
the role of bone marrow-derived MSCs, adipose-derived MSCs, tendon sheath 
fibroblasts and epitendon tenocytes in tendon engineering by seeding them into 
acellularized allogenic tendons as flexor tendon grafts using a rabbit model. 
Histologically, the seeded tendon grafts were indistinguishable between the 
different experimental groups. Because all 4 cell types showed similar growth 
patterns, it was suggested that successful in vivo implantation of the reseeded 
acellularized tendon grafts could be achieved using these cells.  
Therefore, further studies on the investigation of elasticity should considered 
comparing different types of cells and scaffolds subdivided into experimental 
groups. In this way the influence of cells and scaffolds on tendon healing would 
be investigated in a more complete and differentiated way. 
In line with this suggestions stands a published systematic review by Goh et 
al.109, in which the applicability of implants seeded with cells in tendon repair 
and regeneration was assessed. However, the authors found that the ideal 
scaffold and cell source for tissue engineering remain uncertain. 
  
| 58 
9. Limitations 
 
There are several limitations to the study. First of all, our study’s population as 
well as every single population of all 3 groups (18 Achilles tendons in 9 rabbits, 
6 tendons for every group) was relatively small. Therefore this should be 
addressed in further studies. Second, an in vivo examination of all tendons was 
not performed. Hence, no findings could be stated about a correlation between 
in vivo and ex vivo results. Third, no different seeding densities were applied to 
the collagen matrices. Thus, no information of how density would influence 
elasticity can be given. Fourth, the examination of the tendons 8 weeks after 
surgery might be a reason of the equal amount of collagen I seen in the 
immunohistology. Other time-points may show different amount of collagen I 
between the different groups. 
It has been shown that the subcutaneous fat bodies from around the neck and 
between the scapulae in young rabbits are mostly brown fat tissue110. However 
it is also known that ASCs can be harvested in white and brown fat tissue with 
same multi-potent properties111.However, liposuction or subcutaneous surgery 
in human is rather practiced at sites known for distribution of white adipose 
tissue. Thus, the present results are limited to the rabbit model and further 
research is required to compare ASCs from white and brown fat tissue 
regarding their role in tendon tissue repair.  
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10. Conclusion 
 
Previous studies investigated treatment protocols to improve tendon healing, 
since the repair mechanisms in tendon tissue are limited.  
The present study is the first to establish sonoelastography as a suitable tool to 
monitor tendons elasticity in a reproducible way and offers examiner-
independent assessment of elasticity in Achilles tendon repair. Furthermore, 
sonoelastography allowed the examiner to proof for the first time that ASCs 
have the capability to restore elastic properties of injured Achilles tendon up to 
the same level of uninjured Achilles tendons. 
In conjunctions with previous studies, our results showed the importance of 
stem cell treatment for tendon defects as an alternative approach to improve 
tissue healing. Application of ASCs to tendon tissue rupture site might be an 
opportunity to prevent re-ruptures and may lead to better condition for 
rehabilitation as well as a better outcome due to improved elasticity. 
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15. Addendum 
15.1 Figures 
Figure 1 A drawing scheme of the multi-hierarchical structures of the tendon 
 
Figure 2 Nuchal adipose fat body that was used to harvest adipose tissue 
derived mesenchymal stem cells after surgical preparation 
 
Figure 3 50 ml plastic tube after first centrifugation with 450 g for 10 minutes, 
fraction 6 shows the stem cell pellet 
 
Figure 4 After gastrocnemius tendon dissection insertion of the collagen matrix 
and fixation with a modified Kessler suture technique (a). Scar formation of 
Achilles tendon after 8 weeks of gastrocnemius tendon dissection (b). 
 
Figure 5 LOGIQ®E9 (General Electrics) 
 
Figure 6 Experimental set up including a LOGIQ®E9 
 
Figure 7 Linear high resolution multifrequency probe from 6-15 MHz during 
examination 
 
Figure 8 Achilles tendon covered in ultrasound gel before examination 
 
Figure 9 (a) Adipogenic differentiation of ASCs after 14 days of incubation with 
adipogenic differentiation medium, stained with Oil Red O, (b) negative control 
of ASCs incubated with growth medium for 14 days, also stained with Oil Red O 
 
Figure 10 (a) Osteogenic differentiation of ASCs after 14 days of incubation with 
osteogenic differentiation medium, stained with Alizarin Red, (b) negative 
control of ASCs incubated with growth medium for 14 days, also stained with 
Alizarin Red 
 
Figure 11 Example of sonoelastography for injured tendon tissue treated with 
stem cell seeded matrix (a) and unseeded matrix (b). Statistical analysis (c) 
revealed that autologous ASC treatment significantly lowered (**p<0,001) 
elasticity index of Achilles tendons (0.73, SD±0.26) compared to tendons 
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treated with unseeded matrix (4.02, SD±1.33) but did not differ (n.s., p>0.05) 
from uninjured tendons (1.05, SD±0.40). 
 
Figure 12 A repeated measures ANOVA for each tendon group determined that 
EI did not differ statistically significantly (p>0.05) between all ten time points (1-
10) in each group. This demonstrates that tendon compression during 
elastographic measurement for each group gives reliable results independent of 
the time. Standard deviation of tendons treated with unseeded matrix (SD±1.33) 
were significantly higher (p<0.01) when compared to uninjured (SD±0.40) or 
ASC seeded matrix treated tendon tissue (SD±0.26).  
 
Figure 13 Overlay of phase-contrast and fluorescence microscopy of tendon 
tissue section 8 weeks after implantation. ASCs are labeled with DAPI and can 
be found throughout the tissue section 
 
Figure 14 Fluorescence microscopy of tendon tissue section with DAPI labeled 
ASCs and Texas Red labeled collagen I antibody 
 
Figure 15 Immunhistochemistry of collagen I of (a) the control group (no injury) 
(b) matrix only (c) ASCs seeded matrix; (all 4x magnification) 
 
Figure 16 H&E staining of (a) the control group (10x magnification), (b) matrix 
only (5x magnification), (c) ASCs seeded matrix (4x magnification) 
 
 
15.2 Tables 
 
Table 1 Compilation of cell therapies for tendon healing 
 
Table 2 Preparation of 500 ml growth medium 
 
Table 3 Preparation of 100 ml DAPI working solution 
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Table 4 Preparation of 500 ml growth medium 
 
Table 5 Preparation of 100 ml adipogenic differentiation medium 
 
Table 6 Preparation of 100 ml Oil Red O Working Solution 
 
Table 7 Preparation of 100 ml osteogenic differentiation medium 
 
Table 8 Preparation of 100 ml Alizarin Red S Solution 
 
Table 9 Preparation of working solution eosin 
 
Table 10 Preparation of eosin stock solution 
 
Table 11 Preparation of phloxine B stock solution 
 
Table 12 Preparation of 0,25% working solution acid alcohol 
 
Table 13 Preparation of Working solution hematoyxlin 
 
Table 14 Preparation of working solution lithium carbonate 
 
Table 15 Preparation of peroxidase blocking solution 
 
Table 16 Preparation of 100 ml universal blocking buffer 
 
Table 17 Preparation of PBS-Tween 20 
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Table 18 Preparation of 100 ml antibody dilution buffer 
